Related Experiment Video
Updated: Jun 29, 2026

Embryonic Stem Cell-Derived Endothelial Cells for Treatment of Hindlimb Ischemia
Published on: January 23, 2009
Post-stroke endothelial cell plasticity: A transformational lineage from complete to partial EndoMT.
Siyi Tang1, Cheng Li2, Zhijun Yu3
1School of Pharmacy, Southwest Medical University, 643000, China; Key Laboratory of Medical Electrophysiology, Ministry of Education & Medical Electrophysiological, Key Laboratory of Sichuan Province, (Collaborative Innovation Center for Prevention of Cardiovascular Diseases), Institute of Cardiovascular Research, Southwest Medical University, Luzhou 643000, China.
Endothelial-mesenchymal transition (EndoMT) intermediate states offer a novel target for ischemic stroke treatment. Reversible EndoMT in brain damage presents a critical therapeutic window for intervention.
Area of Science:
- Neuroscience
- Cell Biology
- Pathology
Background:
- Internationalization of vascular endothelial cells contributes to ischemic stroke progression.
- Endothelial-mesenchymal transition (EndoMT) is implicated in stroke pathophysiology.
- The blood-brain barrier's integrity is influenced by EndoMT.
Purpose of the Study:
- To review the intermediate states of EndoMT in ischemic stroke.
- To detail key signaling pathways regulating EndoMT.
- To explore the role of EndoMT in blood-brain barrier function during stroke.
Main Methods:
- Literature review focusing on EndoMT and ischemic stroke.
- Analysis of single-cell sequencing data for cellular heterogeneity.
- Examination of pathophysiological processes including TGF-β signaling, transcription factors, and energy metabolism.
Main Results:
- EndoMT exhibits intermediate states, some of which are reversible (MEndT).
- Single-cell sequencing reveals cellular heterogeneity and multiple intermediate phenotypes in EndoMT.
- TGF-β signaling, transcription factors, and energy metabolism are key contributors to EndoMT.
Conclusions:
- Intermediate EndoMT states represent a critical target for preventing ischemic stroke progression.
- Understanding EndoMT heterogeneity provides a basis for novel therapeutic strategies.
- Targeting EndoMT may be crucial for maintaining blood-brain barrier function in stroke.
